X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

IGMS

Closed

Igm Biosciences Inc

1.29
+0.17 (+15.18%)
Last Update: 01 Jul 2025 23:19:00
Yesterday: 1.12
Day's Range: 1.29 - 1.39
Send
When Written:
 
13.96
IGM Biosciences Inc is a clinical-stage biotechnology company that develops engineered IgM antibodies for the treatment of cancer and other diseases. The company's proprietary technology platform enables the creation of IgM antibodies with enhanced efficacy, improved pharmacokinetics, and reduced immunogenicity compared to traditional IgG antibodies.

IGM Biosciences' lead product candidate, IGM-2323, is being developed for the treatment of relapsed/refractory B-cell non-Hodgkin's lymphoma and other B-cell malignancies. The company is also developing a pipeline of other IgM antibodies for the treatment of solid tumors and autoimmune diseases.

IGM Biosciences was founded in 2010 and is headquartered in Mountain View, California. The company went public in 2019 and is listed on the NASDAQ under the ticker symbol "IGMS."

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X